NAFLD or MAFLD: the data behind the debate.
作者信息
Yick Frederick, Hajifathalian Kaveh
机构信息
Department of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, Newark, NJ, USA.
出版信息
Hepatobiliary Surg Nutr. 2022 Jun;11(3):439-442. doi: 10.21037/hbsn-2022-07.
Abstract
摘要
相似文献
1
NAFLD or MAFLD: the data behind the debate.非酒精性脂肪性肝病或代谢功能障碍相关脂肪性肝病：争论背后的数据
Hepatobiliary Surg Nutr. 2022 Jun;11(3):439-442. doi: 10.21037/hbsn-2022-07.
2
The NAFLD-MAFLD debate: Eminence vs evidence.非酒精性脂肪性肝病-代谢功能障碍相关脂肪性肝病之争：权威观点与证据较量
Liver Int. 2021 Feb;41(2):255-260. doi: 10.1111/liv.14739. Epub 2020 Dec 2.
3
Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study.从非酒精性脂肪性肝病到代谢相关性脂肪性肝病的转变中的未决问题：Plinio 研究的经验。
Int J Environ Res Public Health. 2021 Aug 26;18(17):8993. doi: 10.3390/ijerph18178993.
4
MAFLD and CKD: An Updated Narrative Review.MAFLD 和 CKD：更新的叙述性综述。
Int J Mol Sci. 2022 Jun 23;23(13):7007. doi: 10.3390/ijms23137007.
5
NAFLD and MAFLD as emerging causes of HCC: A populational study.非酒精性脂肪性肝病和代谢功能障碍相关脂肪性肝病作为肝细胞癌的新发病因：一项人群研究。
JHEP Rep. 2021 Jan 19;3(2):100231. doi: 10.1016/j.jhepr.2021.100231. eCollection 2021 Apr.
6
NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III.非酒精性脂肪性肝病（NAFLD）还是代谢功能障碍相关脂肪性肝病（MAFLD）：哪种与全因死亡率和特定病因死亡率的关联更紧密？——来自美国国家健康和营养检查调查（NHANES）III的结果
Front Med (Lausanne). 2021 Jul 1;8:693507. doi: 10.3389/fmed.2021.693507. eCollection 2021.
7
Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.从代谢相关脂肪性肝病或非酒精性脂肪性肝病的角度定义的脂肪性肝病患者发生心血管疾病的风险：日本一项回顾性全国索赔数据库研究。
J Gastroenterol. 2021 Nov;56(11):1022-1032. doi: 10.1007/s00535-021-01828-6. Epub 2021 Oct 3.
8
Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study.澳大利亚区域性队列研究中，将非酒精性脂肪性肝病更名为代谢相关性脂肪性肝病的影响：一项前瞻性基于人群的研究结果。
J Gastroenterol Hepatol. 2022 Feb;37(2):395-403. doi: 10.1111/jgh.15723. Epub 2021 Nov 4.
9
Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD.非酒精性脂肪性肝病和/或代谢相关脂肪性肝病患者的临床特征差异及死亡结局。
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2172-2181.e6. doi: 10.1016/j.cgh.2021.05.029. Epub 2021 May 23.
10
Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?非酒精性脂肪性肝病和代谢相关脂肪性肝病患者的心血管事件风险是否存在差异？
Hepatol Int. 2021 Apr;15(2):380-391. doi: 10.1007/s12072-021-10157-y. Epub 2021 Mar 10.
引用本文的文献
1
The Transition of Cardiovascular Disease Risks from NAFLD to MAFLD.心血管疾病风险从非酒精性脂肪性肝病向代谢功能障碍相关脂肪性肝病的转变。
Rev Cardiovasc Med. 2023 May 31;24(6):157. doi: 10.31083/j.rcm2406157. eCollection 2023 Jun.
本文引用的文献
1
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.代谢相关脂肪性肝病与全因死亡率增加相关在美国。
J Hepatol. 2021 Dec;75(6):1284-1291. doi: 10.1016/j.jhep.2021.07.035. Epub 2021 Aug 8.
2
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease.瘦型非酒精性脂肪性肝病患者心血管风险增加。
Gut Liver. 2022 Mar 15;16(2):290-299. doi: 10.5009/gnl210084.
3
Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.瘦素型非酒精性脂肪性肝病：与代谢失调和心血管风险的相关性——一项单中心横断面研究。
Clin Transl Gastroenterol. 2021 Apr 5;12(4):e00326. doi: 10.14309/ctg.0000000000000326.
4
The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017.非酒精性脂肪性肝病所致残疾负担日益加重：2007 - 2017年全球疾病负担数据
Hepatol Commun. 2020 Sep 14;4(12):1769-1780. doi: 10.1002/hep4.1599. eCollection 2020 Dec.
5
Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease.代谢相关脂肪性肝病新定义对该疾病流行病学的影响。
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2161-2171.e5. doi: 10.1016/j.cgh.2020.10.046. Epub 2020 Oct 31.
6
From NAFLD to MAFLD: Implications of a Premature Change in Terminology.从非酒精性脂肪性肝病到代谢相关脂肪性肝病：术语过早改变的影响。
Hepatology. 2021 Mar;73(3):1194-1198. doi: 10.1002/hep.31420. Epub 2021 Feb 6.
7
Comparison of MAFLD and NAFLD diagnostic criteria in real world.现实世界中MAFLD与NAFLD诊断标准的比较。
Liver Int. 2020 Sep;40(9):2082-2089. doi: 10.1111/liv.14548. Epub 2020 Jul 26.
8
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD：代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
9
Non-alcoholic fatty liver disease in lean individuals.瘦人非酒精性脂肪性肝病
JHEP Rep. 2019 Aug 30;1(4):329-341. doi: 10.1016/j.jhepr.2019.08.002. eCollection 2019 Oct.
10
Associations Between Hepatitis B Virus Infection and Risk of All Cancer Types.乙型肝炎病毒感染与所有癌症类型风险的关联。
JAMA Netw Open. 2019 Jun 5;2(6):e195718. doi: 10.1001/jamanetworkopen.2019.5718.
Zotero 插件